Company Overview

Update
Founded:
2006
Founders:
John Mantsch, David A. Baker
Headquarters:
Milwaukee, WI
Funding:
$5.30M
Categories:
Biotechnology

Promentis Pharmaceuticals focuses on developing antipsychotic drugs to treat schizophrenia.

Description

Update

Promentis Pharmaceuticals Inc. discover, develop and market new drugs for the treatment of important human diseases, focusing initially on developing a new antipsychotic drug to treat schizophrenia. Promentis Pharmaceuticals Inc. was founded in 2006 and is based in Milwaukee, Wisconsin.

Current Team (2)

Update

Board Members and Advisors (1)

Update

Funding Rounds (3) - $5.30M

Update

Investors (1)

Update

Offices/Locations (1)

Update
  • Office

    826 N. PLANKINTON AVE., STE. 400

    Milwaukee, WI 53203

    USA

Images (1)

Update
  • 57ed8446fa8b130514bd344b6addf346